Barrington, RI, United States of America

James W Darnowski

USPTO Granted Patents = 11 

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 1990-2009

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James W. Darnowski

Introduction

James W. Darnowski is a notable inventor based in Barrington, Rhode Island, with a remarkable portfolio of 11 patents. His work primarily focuses on innovative methods for treating tumors, showcasing his commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest patents, Darnowski has developed a method utilizing taurolidine to treat tumors. This invention provides a method of inhibiting tumor growth in mammals by administering a composition containing taurolidine, taurultam, or a biologically active derivative thereof. The composition is designed to directly contact tumor cells at a dose sufficient to induce cell death by apoptosis. This innovative approach highlights the potential of taurolidine in cancer treatment.

Career Highlights

Darnowski has made significant contributions to the field of oncology through his research and inventions. His work has been instrumental in developing new therapeutic strategies that aim to enhance the efficacy of cancer treatments. His dedication to research and innovation has positioned him as a key figure in the medical community.

Collaborations

Throughout his career, Darnowski has collaborated with esteemed colleagues, including Paul Calabresi and Michael C. Wiemann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.

Conclusion

James W. Darnowski's contributions to the field of tumor treatment through his innovative patents reflect his dedication to improving healthcare. His work continues to inspire future advancements in medical science and cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…